Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV‐negative veterans

Persons living with HIV/AIDS have a higher incidence of virus‐related and tobacco/alcohol‐related cancers. This study is the first to estimate the effect of HIV versus HIV‐negative veterans on the risk of head and neck squamous cell carcinoma incidence in a large retrospective cohort study.

[1]  A. Mazul,et al.  Incidence and survival for oropharynx and non‐oropharynx head and neck cancers among veterans living with HIV , 2020, Cancer medicine.

[2]  J. Buer,et al.  Oral Neutrophils: Underestimated Players in Oral Cancer , 2020, Frontiers in Immunology.

[3]  R. Pfeiffer,et al.  Deaths attributable to cancer in the United States HIV population during 2001-2015. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Gillison,et al.  Long-term Persistence of Oral HPV Over 7 Years of Follow-up , 2020, JNCI cancer spectrum.

[5]  M. Friend,et al.  Diagnoses of HIV infection in the United States and dependent areas (updated), 2018 , 2020 .

[6]  R. Burk,et al.  HIV modifies the effect of tobacco smoking on oral human papillomavirus infection. , 2020, The Journal of infectious diseases.

[7]  A. Thrift,et al.  Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study. , 2019, Journal of acquired immune deficiency syndromes.

[8]  A. Thrift,et al.  Validation of HIV‐infected cohort identification using automated clinical data in the Department of Veterans Affairs , 2019, HIV medicine.

[9]  M. Verma,et al.  Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer , 2019, Technology in cancer research & treatment.

[10]  A. Chaturvedi,et al.  Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus‐infected individuals in the United States , 2018, Cancer.

[11]  A. Thrift,et al.  Are Non-HIV Malignancies Increased in the HIV-Infected Population? , 2018, Current Infectious Disease Reports.

[12]  E. Wherry,et al.  Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease , 2018, PLoS pathogens.

[13]  M. Lizano,et al.  Type‐specific persistence and clearance rates of HPV genotypes in the oral and oropharyngeal mucosa in an HIV/AIDS cohort , 2018, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[14]  E. Engels,et al.  Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. , 2017, The lancet. HIV.

[15]  S. J. Henley,et al.  Human Papillomavirus-Associated Cancers - United States, 2008-2012. , 2016, MMWR. Morbidity and mortality weekly report.

[16]  G. D’Souza,et al.  Epidemiology of head and neck cancer , 2008 .

[17]  Ross D. Cranston,et al.  Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. , 2015, American journal of epidemiology.

[18]  Richard D Moore,et al.  Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. , 2014, Oral oncology.

[19]  James J. Goedert,et al.  Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada , 2013, PloS one.

[20]  E. Engels,et al.  Invited commentary: Biological and clinical insights from epidemiologic research into HIV, HPV, and anal cancer. , 2013, American journal of epidemiology.

[21]  M. Friend,et al.  Diagnoses of HIV infection in the United States and dependent areas, 2016 , 2013 .

[22]  H. Lando,et al.  Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies , 2012, Current HIV/AIDS Reports.

[23]  Ross D. Cranston,et al.  Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[24]  J. Goedert,et al.  Cancer burden in the HIV-infected population in the United States. , 2011, Journal of the National Cancer Institute.

[25]  T. Iftner,et al.  Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. , 2010, Journal of the National Cancer Institute.

[26]  R. Shaw,et al.  Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. , 2010, Oral oncology.

[27]  B. Gazzard,et al.  Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  P. Sullivan,et al.  Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. , 2008, Annals of internal medicine.

[29]  S. Morinière.  [Epidemiology of head and neck cancer]. , 2006, La Revue du praticien.

[30]  J. Goedert,et al.  Trends in cancer risk among people with AIDS in the United States 1980–2002 , 2006, AIDS.

[31]  Richard D Moore,et al.  Elevated incidence of lung cancer among HIV-infected individuals. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Olivia Keiser,et al.  Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. , 2005, Journal of the National Cancer Institute.